“…In contrast, median raphe lesions did not prevent the effect of PCA on plasma prolactin levels. In summary, these data support the hypothesis that release of serotonin increases prolactin secretion, in addition, these data suggest that serotonergic neurons in the dorsal raphe nucleus are part of a neural pathway which can mediate increases in prolactin se cretion.There is considerable pharmacological evidence sup porting the hypothesis that activation of the serotonergic pathways in the central nervous system results in increased prolactin secretion [1,[6][7][8][9][25][26][27][28], The majority of central serotonergic neurons originate in the dorsal and median raphe nuclei in the hindbrain [2][3][4][5]12] and project rostrally, innervating hypothalamic and rostral limbic and cortical areas [2,33,36.42.43].Since serotonin (5-HT) does not cross the blood-brain barrier [14], various pharmacological agents have been uti lized to examine the regulatory functions of the serotoner gic projections.DT-p-chloroamphetamine (PCA) is a drug which affects catecholamine neurotransmission [11,15,21,37,38,40] and has a biphasic effect on brain serotonin. In the initial few hours it causes a substantial release [18,30,41] followed by long-term inhibition of tryptophan hydroxylase, serotonin uptake, monoamine oxidase and depletion of serotonin stores [37,38].…”